Summit Therapeutics Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Miami, FL
SMMT chart
What traders are saying about $SMMT
Latest postsSummit Therapeutics Inc. news
- Summit Therapeutics (SMMT) Stock Looks Richly Priced On Its 7x Run
Yahoo Finance ·
- FDA Decision Watch: Summit’s Lung Cancer Drug, Cytokinetics’ Heart Therapy And Teva’s Igalmi In Spotlight This Week
stocktwits.com ·
- Biotech Beats SPY And QQQ In Market Rout — Now Hims Earnings And Summit’s FDA Test Take Center Stage
stocktwits.com ·
- Summit Therapeutics Secures $2 Billion AstraZeneca Investment as Ivonescimab Program Advances
Oncodaily ·
- Summit Therapeutics Stock Losses Narrow As Share Increase Is Approved
Simply Wall St ·
- SUMMIT THERAPEUTICS INC (SMMT) Stock Chart
ChartMill ·
- Summit Therapeutics Inc. (SMMT) stock price, news, quote and history
Yahoo Finance Singapore ·
- Summit Therapeutics Stock Price Forecast. Should You Buy SMMT?
StockInvest.us ·
- Summit Therapeutics (SMMT) Earnings Dates, Call Summary & Reports
TipRanks ·
- Summit Therapeutics (NasdaqGM:SMMT) Stock Forecast & Analyst Predictions
Simply Wall St ·
- Summit Therapeutics stock falls 12.3% after financial results
Traders Union ·
- Stifel cuts Summit Therapeutics stock price target on valuation
Investing.com ·
Summit Therapeutics Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | $0 | $0 | $705,000 |
| Net income | -$1.08B | -$221.3M | -$614.9M | -$78.8M |
| Diluted EPS | $-1.44 | $-0.31 | $-0.99 | $-0.41 |
| Total assets (year end) | $751.2M | $435.6M | $202.9M | $664.2M |
| Cash and equivalents (year end) | $225.3M | $104.9M | $71.4M | $348.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Summit Therapeutics Inc.
- Ticker
- SMMT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Miami, FL
- Fiscal year end
- December 31
- SEC CIK
- 1599298
- Former names
- Summit Therapeutics plc, Summit Corp plc
Frequently asked questions
What exchange is Summit Therapeutics Inc. listed on?
Summit Therapeutics Inc. trades on the Nasdaq under the ticker symbol SMMT.
What industry is Summit Therapeutics Inc. in?
Summit Therapeutics Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Summit Therapeutics Inc. headquartered?
Summit Therapeutics Inc.'s business address on file with the SEC is in Miami, FL.
When does Summit Therapeutics Inc.'s fiscal year end?
Summit Therapeutics Inc.'s fiscal year ends on December 31.
How much revenue did Summit Therapeutics Inc. report?
Summit Therapeutics Inc. reported $0 in revenue for calendar year 2024, according to its SEC filings.